On Wednesday we were delighted to host our New York drinks reception, bringing together the CEOs of several of our portfolio companies focused on US expansion, advisers and friends of the firm.
It is just over a year since we opened our New York office, with a mandate to help our European portfolio companies expand into North America, particularly through transformative acquisitions, and to support prospective new investments with clear transatlantic ambitions.
During the evening, Managing Partner Flor Kassai and Ben Meyer, Partner and Head of North America, reflected on the momentum the team has built: more than 350 opportunities evaluated so far this year and executing four strategic investments since office inception, including Rosemont Pharmaceutical’s definitive merger agreement to acquire Aytu BioPharma, announced this week.
We were also proud to be joined by CitySquash, which the Inflexion Foundation has partnered with to support its mission to help motivated and talented young people from disadvantaged households fulfil their academic, athletic and personal potential. Hearing about their work was one of the highlights of the evening.
Thank you to everyone who joined us. We look forward to building on this momentum to further expand our efforts in North America.